ArticleCureus2026

Nephrotic Syndrome During Ipilimumab Plus Nivolumab Therapy for Sarcomatoid Malignant Pleural Mesothelioma: A Case Report of Nivolumab Rechallenge Without Recurrence of Nephrotic Syndrome.

Kazuhiro Shimaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.